Shuttle Pharmaceuticals Holdings (SHPH) Net Equity Issued and Repurchased (2022 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Net Equity Issued and Repurchased of $3.2 million for Q1 2026, down 40.38% year-over-year from $5.4 million in Q1 2025, and down 40.38% quarter-over-quarter from $5.4 million in Q1 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Net Equity Issued and Repurchased (2022 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at $3.2 million for Q1 2026.
- In Q1 2026, Net Equity Issued and Repurchased fell 40.38% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $8.6 million (changed N/A YoY), while the FY2024 annual figure was $4.0 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased for Q1 2026 stood at $3.2 million, down from $5.4 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $5.4 million in Q1 2025, with the low at -$23320.0 in Q4 2022.
- The 3-year median for Net Equity Issued and Repurchased is $3.2 million (2026), against an average of $2.9 million.
- Peak annual rise in Net Equity Issued and Repurchased reached 40.38% in 2026, while the deepest fall reached 40.38% in 2026.
- Shuttle Pharmaceuticals Holdings' Net Equity Issued and Repurchased stood at -$23320.0 in 2022, then jumped by 23297.57% to $5.4 million in 2025, then sank by 40.38% to $3.2 million in 2026.
- Business Quant data shows SHPH's Net Equity Issued and Repurchased at $3.2 million in Q1 2026, $5.4 million in Q1 2025, and -$23320.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.93 Mn | 1.93 Mn | - | 3.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.23 Mn |
| Mar 31, 2026 | 3.23 Mn |
| Mar 31, 2025 | 5.41 Mn |
| Mar 31, 2025 | 5.41 Mn |
| Dec 31, 2022 | -23,320.00 |
| Dec 31, 2022 | -23,320.00 |